D'Apolito Elena, Sisalli Maria Josè, Tufano Michele, Annunziato Lucio, Scorziello Antonella
Division of Pharmacology, Department of Neuroscience Reproductive Sciences and Dentistry, Federico II University of Naples, 80131 Napoli, Italy.
Department of Translational Medicine, Federico II University of Naples, 80131 Napoli, Italy.
Antioxidants (Basel). 2024 Apr 29;13(5):547. doi: 10.3390/antiox13050547.
Brain ischemia is one of the major causes of chronic disability and death worldwide. It is related to insufficient blood supply to cerebral tissue, which induces irreversible or reversible intracellular effects depending on the time and intensity of the ischemic event. Indeed, neuronal function may be restored in some conditions, such as transient ischemic attack (TIA), which may be responsible for protecting against a subsequent lethal ischemic insult. It is well known that the brain requires high levels of oxygen and glucose to ensure cellular metabolism and energy production and that damage caused by oxygen impairment is tightly related to the brain's low antioxidant capacity. Oxygen is a key player in mitochondrial oxidative phosphorylation (OXPHOS), during which reactive oxygen species (ROS) synthesis can occur as a physiological side-product of the process. Indeed, besides producing adenosine triphosphate (ATP) under normal physiological conditions, mitochondria are the primary source of ROS within the cell. This is because, in 0.2-2% of cases, the escape of electrons from complex I (NADPH-dehydrogenase) and III of the electron transport chain occurring in mitochondria during ATP synthesis leads to the production of the superoxide radical anion (O), which exerts detrimental intracellular effects owing to its high molecular instability. Along with ROS, reactive nitrosative species (RNS) also contribute to the production of free radicals. When the accumulation of ROS and RNS occurs, it can cause membrane lipid peroxidation and DNA damage. Here, we describe the intracellular pathways activated in brain tissue after a lethal/sub lethal ischemic event like stroke or ischemic tolerance, respectively, highlighting the important role played by oxidative stress and mitochondrial dysfunction in the onset of the two different ischemic conditions.
脑缺血是全球慢性残疾和死亡的主要原因之一。它与脑组织血液供应不足有关,根据缺血事件的时间和强度,会引发不可逆或可逆的细胞内效应。事实上,在某些情况下,如短暂性脑缺血发作(TIA),神经元功能可能会恢复,TIA可能对预防随后的致命性缺血性损伤起到保护作用。众所周知,大脑需要高水平的氧气和葡萄糖来确保细胞代谢和能量产生,并且氧损伤所造成的损害与大脑较低的抗氧化能力密切相关。氧气是线粒体氧化磷酸化(OXPHOS)中的关键因素,在此过程中,活性氧(ROS)的合成可能作为该过程的一种生理性副产物而发生。实际上,线粒体在正常生理条件下除了产生三磷酸腺苷(ATP)外,还是细胞内ROS的主要来源。这是因为,在0.2%-2%的情况下,ATP合成过程中线粒体内电子从复合物I(NADPH-脱氢酶)和电子传递链的复合物III逃逸会导致超氧阴离子自由基(O)的产生,由于其高分子不稳定性,会在细胞内产生有害作用。除了ROS,活性氮(RNS)也会促成自由基的产生。当ROS和RNS积累时,会导致膜脂质过氧化和DNA损伤。在此,我们分别描述了在中风或缺血耐受等致死性/亚致死性缺血事件后,脑组织中激活的细胞内信号通路,强调了氧化应激和线粒体功能障碍在这两种不同缺血状态发生过程中所起的重要作用。